Saltar al contenido
Merck
  • Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.

Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.

Antimicrobial agents and chemotherapy (2007-09-19)
Ruqaiyyah Siddiqui, Abdul Matin, David Warhurst, Monique Stins, Naveed Ahmed Khan
RESUMEN

Cycloheximide, ketoconazole, or preexposure of organisms to cytochalasin D prevented Balamuthia mandrillaris-associated cytopathogenicity in human brain microvascular endothelial cells, which constitute the blood-brain barrier. In an assay for inhibition of cyst production, these three agents prevented the production of cysts, suggesting that the biosynthesis of proteins and ergosterol and the polymerization of actin are important in cytopathogenicity and encystment.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Cicloheximida, from microbial, ≥94% (TLC)
Sigma-Aldrich
Cycloheximide solution, Ready-Made Solution, microbial, 100 mg/mL in DMSO, Suitable for cell culture
Sigma-Aldrich
Cicloheximida, Biotechnology Performance Certified
Sigma-Aldrich
5-Fluorocytosine, nucleoside analog
Sigma-Aldrich
Ketoconazole, 99.0-101.0% (EP, titration), meets EP testing specifications
Supelco
Cicloheximida, PESTANAL®, analytical standard